$ANGO 0.50 Developing

Notable posts

• @wallstengine neutral 65 eng

  Today's Key Events (All EST) — 07/14/2026 06:00: US NFIB Business Optimism Index 08:15: US ADP Weekly Employment Change 08:30: US CPI YoY 10:00: Fed Chair Warsh Testifies at Committee 12:40: Fed's Barr 13:00: Fed's Goolsbee 13:30: Fed's Cook 14:55: Fed's Bowman 16:00: US Naval Blockade on Iran Starts 16:00: US TIC Long-Term Transactions Before Open 👇 02:00: Ericsson $ERIC 06:00: AngioDynamics $ANGO 06:35: JPMorgan $JPM 06:40: Wells Fargo $WFC 06:45: Bank of America $BAC 06:50: Fastenal $FAST 07:25: Goldman Sachs $GS 07:30: Americas CarMart $CRMT 08:00: Citigroup $C After Hours 👇 16:00: Kestra Medical Technologies $KMTS 16:05: Aehr Test Systems $AEHR 16:05: Phoenix Education Partners $PXED 16:30: Equity Bancshares $EQBK 16:50: Loop Industries $LOOP

  view on X →
• @wallstengine neutral 31 eng

  $ANGO Q4 EARNINGS HIGHLIGHTS 🔹 Revenue: $86.61M (Est. $80.24M) 🟢 🔹 EPS: $(0.07) (Est. $(0.09)) 🟢 FY Guide: 🔹 Revenue: $336M-$341M (Est. $314M) 🟢 🔹 Adjusted EPS: ($0.29)-($0.24) (Est. $(0.20)) 🔴 🔹 Med Tech Net Sales Growth: 12%-15% 🔹 Med Device Net Sales Growth: Flat 🔹 Gross Margin: 54%-55% 🔹 Adjusted EBITDA: $13.0M-$16.0M Q4 Segment Net Revenue: 🔹 Med Tech: $150.0 million; +18.4% YoY 🔹 Med Device: $170.2 million; +2.5% YoY Other Q4 Metrics: 🔹 Adjusted EBITDA: $3.3 million 🔹 Med Device Net Sales: $44.8 million; +1.1% YoY Comments: 🔸 “Full-year Med Tech growth of more than 18% reflects the continued progress of our strategic transformation, as our innovative platform technologies across cardiology and interventional oncology took share in large, fast-growing global markets.” 🔸 “Med Tech represented 47% of our total revenue in fiscal 2026, up approximately 22% from when we began our strategic transformation in 2020.”

  view on X →